TABLE 3.
Vital signs for all patients according to surgical group and analgesic treatment
| Group 1: ITO (PVS) (n=58) | Group 2: IVM (PVS) (n=10) | Group 3: ITO (PVS/TVH) (n=40) | Group 4: IVM (PVS/TVH) (n=13) | |
|---|---|---|---|---|
| HR 6 h | 75±14 | 82±11 | 77±11 | 77±14 |
| HR 12 h | 79±15 | 92±14 | 81±12 | 80±18 |
| HR 18 h | 79±13 | 91±7 | 80±13 | 81±16 |
| HR 24 h | 78±4 | 89±14 | 80±11 | 82±14 |
| HR 36 h | 84±12 | 85±17 | ||
| HR 48 h | 82±12 | 82±11 | ||
| Sat 6 h | 98±2 | 92* | 99±1 | 97±4* |
| Sat 12 h | 98±2 | 92* | 98±2 | 98±1* |
| Sat 18 h | 97±2 | N/A | 98±1 | N/A |
| Sat 24 h | 97±2 | N/A | 98±1 | N/A |
| Sat 36 h | 99±1 | N/A | ||
| Sat 48 h | 99±1 | N/A | ||
| RR 6 h | 19±1 | 18±3 | 19±2 | 19±2 |
| RR 12 h | 20±2 | 19±2 | 19±2 | 20±2 |
| RR 18 h | 20±1 | 19±1 | 19±1 | 19±2 |
| RR 24 h | 20±1 | 21±2 | 19±1 | 20±1 |
| RR 36 h | 20±1 | 19±1 | ||
| RR 48 h | 19±2 | 19±1 | ||
| MAP 6 h | 81±15 | 85±13 | 78±9 | 88±10 |
| MAP 12 h | 77±15 | 84±11 | 71±8 | 84±12 |
| MAP 18 h | 77±14 | 82±8 | 75±10 | 76±6 |
| MAP 24 h | 75±20 | 87±14 | 77±11 | 76±5 |
| MAP 36 h | 84±11 | 85±14 | ||
| MAP 48 h | 86±10 | 81±10 |
Data are presented as mean ± SD.
*
Insufficient sample number to calculate SD and statistical testing. HR Heart rate in beats/min; ITO Intrathecal opioid; IVM Intravenous morphine; MAP Noninvasive mean arterial blood pressure in mmHg; N/A Not applicable (not measured); PVS Pubovaginal sling; RR Respiration rate in breaths/min; Sat Pulse oximetry saturation in %; TVH Total vaginal hysterectomy